Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Toronto, Ontario, Canada
SEC filing record 1 source field available
Fiscal year end
30 November
Intellipharmaceutics International Inc. has filed 473 SEC EDGAR filings since 22 Oct 2009

SEC filing history

Showing 1-19 of 19 matching filings.

Per page
25
Current page
1
20-F/A File 000-53805

FORM 20-F/A

Filing date
06 Feb 2024
Reporting date
30 Nov 2022
Next action
Verify source filing
20-F/A File 000-53805

FORM 20-F/A

Filing date
09 May 2022
Reporting date
30 Nov 2021
Next action
Verify source filing
20-F File 000-53805

PRIMARY DOCUMENT

Filing date
31 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
20-F File 000-53805

PRIMARY DOCUMENT

Filing date
30 Mar 2020
Reporting date
30 Nov 2019
Next action
Verify source filing
20-F/A File 000-53805

PRIMARY DOCUMENT

Filing date
04 Mar 2019
Reporting date
28 Feb 2019
Next action
Verify source filing
20-F File 000-53805

PRIMARY DOCUMENT

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
Next action
Verify source filing
20-F File 000-53805

PRIMARY DOCUMENT

Filing date
28 Feb 2017
Reporting date
27 Feb 2017
Next action
Verify source filing
20-F/A File 000-53805

FORM 20-F/A (AMENDMENT NO. 1)

Filing date
14 Apr 2014
Reporting date
30 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F/A File 000-53805

FORM 20-F/A

Filing date
01 Feb 2013
Reporting date
30 Nov 2012
Next action
Verify source filing
20-F File 000-53805

FORM 20-F

Filing date
31 Jan 2013
Reporting date
30 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 000-53805

FORM 20-F

Filing date
31 May 2011
Reporting date
30 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 000-53805

FORM 20-F

Filing date
01 Jun 2010
Reporting date
30 Nov 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .